Proximal tubule haptoglobin gene activation is an integral component of the acute kidney injury "stress response"

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 1, 2012, Pages

  Zager, Richard A ^a,b   Vijayan, Anitha ^c   Johnson, Ali C M ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

Acute renal failure; Cisplatin; Ischemia; Obstruction; Rhabdomyolysis

Indexed keywords

CISPLATIN; GLYCEROL; HAPTOGLOBIN; MESSENGER RNA;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE ACTIVATION; GENE INDUCTION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; MYOGLOBINURIA; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REPERFUSION INJURY; STRESS; URETER OBSTRUCTION; WESTERN BLOTTING;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; ANIMALS; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; FEMALE; GENE EXPRESSION; HAPTOGLOBINS; HUMANS; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MIDDLE AGED; REPERFUSION INJURY; TRANSCRIPTIONAL ACTIVATION; URETERAL OBSTRUCTION;

EID: 84863331307     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00168.2012     Document Type: Article

References (39)

1. Alper CA, Peters JH, Birth AG, Gardner FH. Haptoglobin synthesis. I. In vivo studies of the production of haptoglobin, fibrinogen, and _-globulin by the canine liver. J Clin Invest 44: 574-581, 1965.
2. Alper CA, Raum D, Awdeh ZL, Peterson BH, Taylor PD, Starzl TE. Studies of hepatic synthesis in vivo of plasma proteins, including orosomucoid, transferrin, _1 antitrypsin, C8, and factor B. Clin Immunol Immunopathol 16: 84-89, 1980.
3. Arredouani MS, Kasran A, Vanoirbeek JA, Berger FG, Baumann H, Ceuppens JL. Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo. Immunology 114: 263-271, 2005.
4. Arredouani M, Matthys P, Kasran A, Baumann H, Ceuppen JL. Haptoglobin and the Th1/Th2 balance: hints from in vitro and in vivo studies. Redox Rep 6: 369-371, 2001.
5. Arredouani M, Matthijs P, Van Hoeyveld E, Kasran A, Baumann H, Ceuppens JL, Stevens E. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 108: 144-151, 2003.
6. Asleh R, Levy AP. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease. Vasc Health Risk Manag 1: 19-28, 2005.
7. Blum S, Asaf R, Guetta J, Miller-Lotan R, Asleh R, Kremer R, Levy NS, Berger FG, Aronson D, Fu X, Zhang R, Hazen SL, Levy AP. Haptoglobin genotype determines myocardial infarct size in diabetic mice. J Am Coll Cardiol 49: 82-87, 2007.
8. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 66: 480-485, 2004.
9. Boretti FS, Buehler PW, D'Agnillo F, Kluge K, Glaus T, Butt OI, Jia Y, Goede J, Pereira CP, Maggiorini M, Schoedon G, Alayash AI, Schaer DJ. Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs. J Clin Invest 119: 2271-2280, 2009.
10. Brock M, Trenkmann M, Gay RE, Gay S, Speich R, Huber LC. MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes. J Biol Chem 286: 40142-40150, 2011.
11. Chen YC, Lee CC, Huang CY, Huang HB, Yu CC, Ho YC, Su YC. Haptoglobin polymorphism as a risk factor for chronic kidney disease: a case-control study. Am J Nephrol 33: 510-514, 2011.
12. Conway BR, Savage DA, Brady HR, Maxwell AP. Association between haptoglobin gene variants and diabetic nephropathy: haptoglobin polymorphism in nephropathy susceptibility. Nephron Exp Nephrol 105: e75-e79, 2007.
13. El-Ghmati SM, Arredouani M, Van Hoeyveld EM, Ceuppens JL, Stevens EA. Haptoglobin interacts with the human mast cell line HMC-1 and inhibits its spontaneous proliferation. Scand J Immunol 55: 352-358, 2002.
14. Galicia G, Maes W, Verbinnen B, Kasran A, Bullens D, Arredouani M, Ceuppens JL. Haptoglobin deficiency facilitates the development of autoimmune inflammation. Eur J Immunol 39: 3404-342, 2009.
15. Giannakis E, Samuel CS, Hewitson TD, Boon WM, Macris M, Reeve S, Lawrence J, Ian Smith A, Tregear GW, Wade JD. Aberrant protein expression in plasma and kidney tissue during experimental obstructive nephropathy. Proteomics Clin Appl 3: 1211-1224, 2009.
16. Kato GJ. Haptoglobin halts hemoglobin's havoc. J Clin Invest 119: 2140-2142, 2009.
17. Kim H, Baumann H. The carboxyl-terminal region of STAT3 controls gene induction by the mouse haptoglobin promoter. J Biol Chem 272: 14571-14579, 1997.
18. Korrapati MC, Shaner BE, Schnellmann RG. Recovery from glycerolinduced acute kidney injury is accelerated by suramin. J Pharmacol Exp Ther 341: 126-136, 2012.
19. Lim YK, Jenner A, Bin Ali A, Wang Y, IHong Hsu S, Chong SM, Baumman H, Halliwell B, Lim SK. Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazine-induced hemolysis. Kidney Int 58: 1033-1044, 2000.
20. Nakhoul FM, Miller-Lotan R, Awaad H, Asleh R, Levy AP. Hypothesis-haptoglobin genotype and diabetic nephropathy. Nat Clin Pract Nephrol 3: 339-344, 2007.
21. Oh MK, Park HJ, Kim NH, Part SJ, Park IY, Kim IN. Hypoxia inducibe factor-1_ enhances haptoglobin gene expression by improving binding of STAT3 to the promoter. J Biol Chem 286: 8857-8865, 2011.
22. Peters JH, Alper CA. Haptoglobin synthesis. II. Cellular localization studies. J Clin Invest 45: 314-320, 1965.
23. Pintera J, Tomásěk V. The protective influence of haptoglobin on hemoglobinuric kidney. II. Microscopic observations and clinical aspect. Int Z Klin Pharmakol Ther Toxikol 4: 371-377, 1970.
24. Polticelli F, Bocedi A, Minervini G, Ascenzi P. Human haptoglobin structure and function-a molecular modelling study. FEBS J 275: 5648-5656, 2008.
25. Quaye IK. Haptoglobin, inflammation disease. Trans R Soc Trop Med Hyg 102: 735-742, 2008.
26. Sadrzadeh SM, Bozorgmehr J. Haptoglobin phenotypes in health and disease. Am J Clin Pathol 121: S97-S104, 2004.
27. Sakata S, Yoshioka N, Atassi MZ. Human haptoglobin binds to human myoglobin. Biochim Biophys Acta 873: 312-315, 1986.
28. Shen H, Song Y, Colangelo CM, Wu R, Bruce C, Scabia G, Galan A, Maffei M, Goldstein DR. Haptoglobin activates innate immunity to enhance acute transplant rejection in mice. J Clin Invest 122: 383-387, 2012.
29. Tadagavadi RK, Reeves WB. Endogenous IL-10 attenuates cisplatin nephrotoxicity: role of dendritic cells. J Immunol 185: 4904-4911, 2010.
30. Tseng CF, Lin CC, Huang HY, Liu HC, Mao SJ. Antioxidant role of human haptoglobin. Proteomics 4: 2221-2228, 2004.
31. Uskoković A, Dinić S, Mihailović M, Grdović N, Arambaǐć J, Vidaković M, Bogojević D, Ivanović-Matić S, Martinović V, Petrović M, Poznanov́i G, Grigorov I. STAT3/NF-B interactions determine the level of haptoglobin expression in male rats exposed to dietary restriction and/or acute phase stimuli. Mol Biol Rep 39: 167-176, 2012.
32. Vercellotti GM, Balla G, Balla J, Nath K, Eaton JW, Jacob HS. Heme and the vasculature: an oxidative hazard that induces antioxidant defenses in the endothelium. Artif Cells Blood Substit Immobil Biotechnol 22: 207-213, 1994.
33. Vernochet C, Davis KE, Scherer PE, Farmer SR. Mechanisms regulation repression of haptoglobin production by peroxisome proliferativeactivated receptor-_ ligands in adipocytes. Endocrinology 151: 586-594, 2010.
34. Ware LB, Johnson AC, Zager RA. Renal cortical albumin gene induction and urinary albumin excretion in response to acute kidney injury. Am J Physiol Renal Physiol 300: F628-F638, 2011.
35. Wobeto VP, Garcia PM, Zaccariotto TR, Sonati Mde F. Haptoglobin polymorphism and diabetic nephropathy in Brazilian diabetic patients. Ann Hum Biol 36: 437-441, 2009.
36. Yoshioka T, Sugimoto T, Ukai T, Oshiro T. Haptoglobin therapy for possible prevention of renal failure following thermal injury: a clinical study. J Trauma 25: 281-288, 1985.
37. Zager RA, Johnson AC, Becker K. Acute unilateral ischemic renal injury induces progressive renal inflammation, lipid accumulation, histone modification, and "end-stage" kidney disease. Am J Physiol Renal Physiol 301: F1334-F1345, 2011.
38. Zager RA, Johnson AC, Lund S, Hanson S. Acute renal failure: determinants and characteristics of the injury-induced hyperinflammatory response. Am J Physiol Renal Physiol 291: F546-F556, 2006.
39. Zager RA, Schimpf BA, Gmur DJ, Burke TJ. Phospholipase A2 activity can protect renal tubules from oxygen deprivation injury. Proc Natl Acad Sci U S A 90: 8297-82301, 1993.